Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-17-003205

SVP, Chief Business Officer sold 1,398 shares at $19.64 ($27,457)

From the SEC's structured data for this filing

Trades in this filing

Dahan Michel · SVP, Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-10-02 Sale : show line 1 in the form −1,398 $19.64 $27,457 95,826 D
Open-market sales · 1,398 sh · avg $19.64 · $27,457
Loading xslF345X03/primarydocument.xml…